Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
GLP-1s and Hair Thinning: Expert Advice for Management - Featured image
Health

GLP-1s and Hair Thinning: Expert Advice for Management

Hair loss, or 'GLP-1 shedding,' can be a concerning side effect for those using GLP-1 drugs. However, solutions are available to effectively address this issue. A dermatologist provides insights into managing hair loss associated with these medications.

Shotlee·November 12, 2025·Updated Jan 26, 2026·4 min read
Share:

Contents

  1. 01GLP-1s and Hair Thinning: Expert Advice for Management
  2. 02Different Demographics in Hair Loss
  3. 03Understanding the Causes
  4. 04Timing Is Key
  5. 05Self-Care Options at Home
  6. 06Medical Solutions
  7. 07Continuing GLP-1 Treatment

GLP-1s and Hair Thinning: Expert Advice for Management

While using GLP-1 medications, hair loss might seem alarming, but often it's not as critical as it appears.

Many things in life involve tradeoffs, and GLP-1 drugs are no exception. Initially touted as a revolutionary solution for obesity and excess weight, a notable side effect has emerged: sudden and sometimes significant hair loss.

This phenomenon, termed GLP-1 "shedding," leads some users to feel they've exchanged weight for persistent hair problems. Fortunately, solutions exist to effectively manage this particular concern.

Different Demographics in Hair Loss

Understanding this type of hair loss starts with recognizing its unique demographics. Hair loss is often perceived as a primarily male issue, but GLP-1 data challenges this assumption.

According to Dr. Ellen Marmur, a board-certified dermatologist and founder of MMSkincare, hair loss is reported more frequently in women than in men in GLP-1 medication trials. Approximately seven percent of women experience hair loss, compared to less than one percent of men. Typically, shedding is described as mild to moderate and is often associated with rapid weight changes caused by these medications.

Understanding the Causes

This hair loss is classified as telogen effluvium, affecting individuals across all age groups. The severity is categorized as mild, moderate, or severe, based on the degree of hair thinning.

Causes can vary. Major stressors such as surgery or childbirth are common triggers, but even less significant stressors like moving or school exams can contribute due to their impact on emotional and physical well-being. The good news, according to Marmur, is that it's frequently temporary.

"GLP-1 hair loss isn't directly from the medication, it is from the rapid weight loss and most often self-corrects within 3-6 months," she says.

Timing Is Key

Most individuals experiencing hair loss want to determine if it's linked to GLP-1 use. Marmur suggests that timing is crucial.

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester

"The biggest indicator is timing," she explains. "GLP-1-related shedding usually starts two to three months after a significant body change, such as rapid weight loss or a dosage adjustment. Hair tends to fall out evenly across the scalp, and the scalp typically appears healthy. This pattern is different from genetic thinning or inflammatory scalp conditions."

Self-Care Options at Home

Another positive aspect is the availability of self-care options that don't necessarily require a dermatologist's direct involvement. Health tracking apps like Shotlee can help monitor nutritional intake, which is vital for hair health.

"At home, focus on gentle scalp care and good nutrition, including protein, iron, zinc, and vitamin D," Marmur advises.

If these measures prove insufficient, consulting a dermatologist might be necessary. Seek professional help if shedding persists for more than 3-4 months, bald patches develop, or scalp issues like itchiness, pain, and inflammation arise.

Medical Solutions

Medical options available through a dermatologist include topical or oral minoxidil, anti-androgens, finasteride (for men), PRP injections, or professional low-level light therapy.

  • Women may be prescribed minoxidil and, in some cases, anti-androgen medications like spironolactone if hormones are a factor.
  • Men can also use minoxidil, and finasteride might be considered for pattern hair loss.

Marmur explains, "One study showed that microdosed Dutasteride for women had fewer side effects than placebo and no unwanted hair growth like minoxidil."

Continuing GLP-1 Treatment

Many individuals are hesitant to discontinue GLP-1 treatment due to concerns about ongoing hair loss. Fortunately, continuing the medication while managing hair loss is often possible.

"In most cases, people can continue their medication and manage the hair loss at the same time," Marmur states. Adjusting the rate of weight loss, increasing protein intake, and using supportive products and treatments can often help.

"Pausing or stopping the medication is rarely necessary and is typically only considered if the shedding is severe or persistent. This decision should always be made with a healthcare provider."

Original source: The Manual

View original article →
#GLP-1#hair loss#telogen effluvium#weight loss#dermatologist#minoxidil
  1. Home
  2. Blog
  3. GLP-1s and Hair Thinning: Expert Advice for Management

Related Articles

Sciwind Biosciences $495M Pfizer China Deal for Ecnoglutide GLP-1
GLP-1 Medications

Sciwind Biosciences $495M Pfizer China Deal for Ecnoglutide GLP-1

Sciwind Biosciences has secured a landmark $495 million commercialization deal with Pfizer China for Ecnoglutide, a next-generation cAMP-biased GLP-1 receptor agonist. Approved for type 2 diabetes in China, it shows 15.1% placebo-adjusted weight loss in trials. This partnership aims to address rising obesity rates amid national health initiatives.

NHS Pays GPs Incentives for Mounjaro, Wegovy Prescriptions
GLP-1 Medications

NHS Pays GPs Incentives for Mounjaro, Wegovy Prescriptions

The UK Government has announced financial incentives for GPs to boost prescriptions of weight-loss injections Mounjaro and Wegovy on the NHS. Eight months into the mass rollout, not all practices are participating, prompting £25 million in funding for fairer access. Health Secretary Wes Streeting calls it a 'game changer' for obesity, but experts warn of workload risks.

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community